200 related articles for article (PubMed ID: 21416397)
1. [Challenges in the organization of investigator initiated trials: in transplantation medicine].
Schnitzbauer AA; Lamby PE; Mutzbauer I; von Hassel J; Geissler EK; Schlitt HJ
Chirurg; 2011 Mar; 82(3):249-54. PubMed ID: 21416397
[TBL] [Abstract][Full Text] [Related]
2. Conflicts of interest in research involving human beings.
Greco D; Diniz NM
J Int Bioethique; 2008; 19(1-2):143-54, 202-3. PubMed ID: 18664007
[TBL] [Abstract][Full Text] [Related]
3. Legal and ethical obligations to conduct a clinical drug trial in Australia as an investigator initiated and sponsored study for an overseas pharmaceutical company.
Beran RG
Med Law; 2004; 23(4):913-24. PubMed ID: 15685926
[TBL] [Abstract][Full Text] [Related]
4. [The ethical challenges of Entrepreneurial Logic].
Guimarães R
Cien Saude Colet; 2019 Sep; 24(9):3583-3594. PubMed ID: 31508775
[TBL] [Abstract][Full Text] [Related]
5. Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT).
Blümle A; Wollmann K; Bischoff K; Kapp P; Lohner S; Nury E; Nitschke K; Zähringer J; Rücker G; Schumacher M
BMC Med Res Methodol; 2021 Aug; 21(1):182. PubMed ID: 34465296
[TBL] [Abstract][Full Text] [Related]
6. Disclosure of competing financial interests and role of sponsors in phase III cancer trials.
Tuech JJ; Moutel G; Pessaux P; Thoma V; Schraub S; Herve C
Eur J Cancer; 2005 Oct; 41(15):2237-40. PubMed ID: 16214044
[TBL] [Abstract][Full Text] [Related]
7. [Basic principles, planning and implementation of non-commercial clinical trials].
Finger RP; Coch C; Coenen M; Mengel M; Hartmann G; Holz FG
Ophthalmologe; 2011 Jan; 108(1):25-32. PubMed ID: 21181167
[TBL] [Abstract][Full Text] [Related]
8. How skeptical should we be about industry-sponsored studies?
Meador KJ
Neurology; 2007 Apr; 68(15):1238; author reply 1238. PubMed ID: 17420417
[No Abstract] [Full Text] [Related]
9. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
10. Ethical considerations in industry-sponsored multiregional clinical trials.
Ibia E; Binkowitz B; Saillot JL; Talerico S; Koerner C; Ferreira I; Agarwal A; Metz C; Maman M
Pharm Stat; 2010; 9(3):230-41. PubMed ID: 20824884
[TBL] [Abstract][Full Text] [Related]
11. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
12. Drug research: marketing before evidence, sales before safety.
Klemperer D
Dtsch Arztebl Int; 2010 Apr; 107(16):277-8. PubMed ID: 20467552
[No Abstract] [Full Text] [Related]
13. Review article: gastroenterology and the pharmaceutical industry.
Rakatansky H
Aliment Pharmacol Ther; 2002 Nov; 16(11):1859-66. PubMed ID: 12390094
[TBL] [Abstract][Full Text] [Related]
14. Academic investigator-initiated trials and the challenge of sponsor responsibility: the Cologne Sponsor Model.
Georgias C; Grunow A; Olderog M; May A; Paulus U
Clin Trials; 2012 Dec; 9(6):781-7. PubMed ID: 23104975
[TBL] [Abstract][Full Text] [Related]
15. Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials.
Hilbrich L; Sleight P
Eur Heart J; 2006 Sep; 27(18):2158-64. PubMed ID: 16870690
[TBL] [Abstract][Full Text] [Related]
16. Sponsors' participation in conduct and reporting of industry trials: a descriptive study.
Lundh A; Krogsbøll LT; Gøtzsche PC
Trials; 2012 Aug; 13():146. PubMed ID: 22920226
[TBL] [Abstract][Full Text] [Related]
17. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.
Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA
Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523
[TBL] [Abstract][Full Text] [Related]
18. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
19. If the Facts Were Not Untruths, Their Implications Were: Sponsorship Bias and Misleading Communication.
Steel D
Kennedy Inst Ethics J; 2018; 28(2):119-144. PubMed ID: 30100597
[TBL] [Abstract][Full Text] [Related]
20. NIH proposes new conflict-of-interest rules for investigators.
Goozner M
J Natl Cancer Inst; 2010 Jul; 102(14):1006-7. PubMed ID: 20616352
[No Abstract] [Full Text] [Related]
[Next] [New Search]
